EC Psychology and Psychiatry

Background: The global prevalence of depression covers about 3.4% of total population of world. It has victimized more than 280 million people worldwide. Depression has affected the people from every sector of life and every age group. The depression being fatal to the physical, psychological and general medical health is under focus of scholars, researchers, psychiatrist, physician and general population.

Objective: The objective of current systematic literature review analysis the qualitative coherence, consensus and difference of research on psychiatrist decision making for treatment of depression in 2022.

Methodology: The methodological framework for this systematic analysis is PRISMA (Preferred Report Items Analysis) protocol.

Data Analysis: About, 25 papers were initially found utilizing the online PubMed library in the EndNote X9 program; no articles were added directly from any other medium or website. Six articles were eliminated using the custom trail year 2022 filter and the duplication effect. By analyzing the articles based on title-based analysis, 11 of the 19 remaining articles were eliminated. Additionally, the eligibility of around 08 articles was evaluated in full text. Five articles in whole were excluded with justifications based on inclusion and exclusion criteria. The full-text papers, which were published in both English and PDF format, included qualitative analysis.

Conclusion: The decision making of psychiatrist for treatment of depression is influenced by various number of factors. It is important for treatment of depression.

Keyword: Decision Making; Psychiatrist; Depression

1. Conway D., et al. “The influence of pain, kinesiophobia and psychological comorbidities on the accuracy of rating of perceived exertion in UK military spinal rehabilitation”. 168.4 (2022): 292-298.
2. Johns G., et al. “The global prevalence of depression and anxiety among doctors during the covid-19 pandemic: Systematic review and meta-analysis”. 298 (2022): 431-441.
3. Mahmud S., et al. “The global prevalence of depression, anxiety, stress, and insomnia among general population during COVID-19 pandemic: A systematic review and meta-analysis”. (2022): 1-28.
4. Jayasingam S., et al. “Depression–A Silent Killer, in Supporting and Sustaining Well-Being in the Workplace: Insights from a Developing Economy”. Emerald Publishing Limited (2020).
5. Rasmus P., et al. “Anxiety and depression among ambulatory and hospitalized patients with cardiovascular long-COVID-19 presentation referred to cardiology consultation after COVID-19 infection”. 43.2 (2022): ehac544.
6. Ustun GJIJoSP. “Determining depression and related factors in a society affected by COVID-19 pandemic”. 67.1 (2021): 54-63.
7. Zheng R., et al. “Prevalence and associated factors of depression and anxiety among nurses during the outbreak of COVID-19 in China: A cross-sectional study”. 114 (2021): 103809.
8. Juszczyk G., et al. “Chronic stress and oxidative stress as common factors of the pathogenesis of depression and Alzheimer’s disease: The role of antioxidants in prevention and treatment”. 10.9 (2021): 1439.
9. Pelly D., et al. “Worker stress, burnout, and wellbeing before and during the COVID-19 restrictions in the United Kingdom”. (2022): 1047.
10. Menear M., et al. “Personalized care planning and shared decision making in collaborative care programs for depression and anxiety disorders: A systematic review”. 17.6 (2022): e0268649.
11. Menear M., et al. “Personalized care planning and shared decision making in collaborative care programs for depression and anxiety disorders: A systematic review”. 17.6 (2021): e0268649.
12. Shabbir MA., et al. “Delving the role of nutritional psychiatry to mitigate the COVID-19 pandemic induced stress, anxiety and depression” (2022).
13. Haddaway NR., et al. “PRISMA2020: An R package and Shiny app for producing PRISMA 2020‐compliant flow diagrams, with interactivity for optimised digital transparency and Open Synthesis”. 18.2 (2022): e1230.
14. Mohsina S., et al. “Assessment of the quality of randomized controlled trials in surgery using Jadad score: Where do we stand?” 68.4 (2022): 207.
15. Currie JM and WBJE MacLeod. “Understanding doctor decision making: The case of depression treatment”. 88.3 (2022): 847-878.
16. Matthews EB., et al. “Shared decision making in primary care based depression treatment: communication and decision-making preferences among an underserved patient population”. (2022): 12.
17. Abousheishaa AA., et al. “Antidepressant decision aid for major depressive disorder patients (ADAM): Development and pilot testing”. 105.7 (2022): 2466-2474.
18. Drake RE., et al. “Shared decision making in mental health: prospects for personalized medicine” (2022).
19. Nelson KL., et al. “Perceptions of patient-provider communication and receipt of mental health treatment among older adults with depressive symptoms”. 23.4 (2019): 485-490.